Factors influencing the prioritization of vaccines by policymakers in low- and middle-income countries: a scoping review
Abstract Vaccination decision making in low- and middle-income countries (LMICs) has become increasingly complex, particularly in the context of numerous competing health challenges. LMICs have to make difficult choices on which vaccines to prioritize for introduction while considering a wide range...
Saved in:
Published in | Health policy and planning Vol. 38; no. 3; pp. 363 - 376 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
UK
Oxford University Press
16.03.2023
Oxford Publishing Limited (England) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract
Vaccination decision making in low- and middle-income countries (LMICs) has become increasingly complex, particularly in the context of numerous competing health challenges. LMICs have to make difficult choices on which vaccines to prioritize for introduction while considering a wide range of factors such as disease burden, vaccine impact, vaccine characteristics, financing and health care infrastructures, whilst adapting to each country’s specific contexts. Our scoping review reviewed the factors that influence decision-making among policymakers for the introduction of new vaccines in LMICs. We identified the specific data points that are factored into the decision-making process for new vaccine introduction, whilst also documenting whether there have been any changes in decision-making criteria in new vaccine introduction over the last two decades. A comprehensive database search was conducted using a search strategy consisting of key terms and Medical Subject Headings (MeSH) phrases related to policy, decision-making, vaccine introduction, immunization programmes and LMICs. Articles were screened following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. A total of 843 articles were identified, with 34 articles retained after abstract screening, full-text screening and grading with the mixed methods appraisal tool (MMAT). The Burchett framework for new vaccine introduction was used to identify indicators for vaccine-decision making and guided data extraction. Articles in our study represented a diverse range of perspectives and methodologies. Across articles, the importance of the disease, which included disease burden, costs of disease and political prioritization, coupled with economic factors related to vaccine price, affordability and financing were the most common criteria considered for new vaccine introduction. Our review identified two additional criteria in the decision-making process for vaccine introduction that were not included in the Burchett framework: communication and sociocultural considerations. Data from this review can support informed decision-making for vaccine introduction amongst policymakers and stakeholders in LMICs. |
---|---|
AbstractList | Vaccination decision making in low- and middle-income countries (LMICs) has become increasingly complex, particularly in the context of numerous competing health challenges. LMICs have to make difficult choices on which vaccines to prioritize for introduction while considering a wide range of factors such as disease burden, vaccine impact, vaccine characteristics, financing and health care infrastructures, whilst adapting to each country’s specific contexts. Our scoping review reviewed the factors that influence decision-making among policymakers for the introduction of new vaccines in LMICs. We identified the specific data points that are factored into the decision-making process for new vaccine introduction, whilst also documenting whether there have been any changes in decision-making criteria in new vaccine introduction over the last two decades. A comprehensive database search was conducted using a search strategy consisting of key terms and Medical Subject Headings (MeSH) phrases related to policy, decision-making, vaccine introduction, immunization programmes and LMICs. Articles were screened following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. A total of 843 articles were identified, with 34 articles retained after abstract screening, full-text screening and grading with the mixed methods appraisal tool (MMAT). The Burchett framework for new vaccine introduction was used to identify indicators for vaccine-decision making and guided data extraction. Articles in our study represented a diverse range of perspectives and methodologies. Across articles, the importance of the disease, which included disease burden, costs of disease and political prioritization, coupled with economic factors related to vaccine price, affordability and financing were the most common criteria considered for new vaccine introduction. Our review identified two additional criteria in the decision-making process for vaccine introduction that were not included in the Burchett framework: communication and sociocultural considerations. Data from this review can support informed decision-making for vaccine introduction amongst policymakers and stakeholders in LMICs. Vaccination decision making in low- and middle-income countries (LMICs) has become increasingly complex, particularly in the context of numerous competing health challenges. LMICs have to make difficult choices on which vaccines to prioritize for introduction while considering a wide range of factors such as disease burden, vaccine impact, vaccine characteristics, financing and health care infrastructures, whilst adapting to each country's specific contexts. Our scoping review reviewed the factors that influence decision-making among policymakers for the introduction of new vaccines in LMICs. We identified the specific data points that are factored into the decision-making process for new vaccine introduction, whilst also documenting whether there have been any changes in decision-making criteria in new vaccine introduction over the last two decades. A comprehensive database search was conducted using a search strategy consisting of key terms and Medical Subject Headings (MeSH) phrases related to policy, decision-making, vaccine introduction, immunization programmes and LMICs. Articles were screened following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. A total of 843 articles were identified, with 34 articles retained after abstract screening, full-text screening and grading with the mixed methods appraisal tool (MMAT). The Burchett framework for new vaccine introduction was used to identify indicators for vaccine-decision making and guided data extraction. Articles in our study represented a diverse range of perspectives and methodologies. Across articles, the importance of the disease, which included disease burden, costs of disease and political prioritization, coupled with economic factors related to vaccine price, affordability and financing were the most common criteria considered for new vaccine introduction. Our review identified two additional criteria in the decision-making process for vaccine introduction that were not included in the Burchett framework: communication and sociocultural considerations. Data from this review can support informed decision-making for vaccine introduction amongst policymakers and stakeholders in LMICs.Vaccination decision making in low- and middle-income countries (LMICs) has become increasingly complex, particularly in the context of numerous competing health challenges. LMICs have to make difficult choices on which vaccines to prioritize for introduction while considering a wide range of factors such as disease burden, vaccine impact, vaccine characteristics, financing and health care infrastructures, whilst adapting to each country's specific contexts. Our scoping review reviewed the factors that influence decision-making among policymakers for the introduction of new vaccines in LMICs. We identified the specific data points that are factored into the decision-making process for new vaccine introduction, whilst also documenting whether there have been any changes in decision-making criteria in new vaccine introduction over the last two decades. A comprehensive database search was conducted using a search strategy consisting of key terms and Medical Subject Headings (MeSH) phrases related to policy, decision-making, vaccine introduction, immunization programmes and LMICs. Articles were screened following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. A total of 843 articles were identified, with 34 articles retained after abstract screening, full-text screening and grading with the mixed methods appraisal tool (MMAT). The Burchett framework for new vaccine introduction was used to identify indicators for vaccine-decision making and guided data extraction. Articles in our study represented a diverse range of perspectives and methodologies. Across articles, the importance of the disease, which included disease burden, costs of disease and political prioritization, coupled with economic factors related to vaccine price, affordability and financing were the most common criteria considered for new vaccine introduction. Our review identified two additional criteria in the decision-making process for vaccine introduction that were not included in the Burchett framework: communication and sociocultural considerations. Data from this review can support informed decision-making for vaccine introduction amongst policymakers and stakeholders in LMICs. Abstract Vaccination decision making in low- and middle-income countries (LMICs) has become increasingly complex, particularly in the context of numerous competing health challenges. LMICs have to make difficult choices on which vaccines to prioritize for introduction while considering a wide range of factors such as disease burden, vaccine impact, vaccine characteristics, financing and health care infrastructures, whilst adapting to each country’s specific contexts. Our scoping review reviewed the factors that influence decision-making among policymakers for the introduction of new vaccines in LMICs. We identified the specific data points that are factored into the decision-making process for new vaccine introduction, whilst also documenting whether there have been any changes in decision-making criteria in new vaccine introduction over the last two decades. A comprehensive database search was conducted using a search strategy consisting of key terms and Medical Subject Headings (MeSH) phrases related to policy, decision-making, vaccine introduction, immunization programmes and LMICs. Articles were screened following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. A total of 843 articles were identified, with 34 articles retained after abstract screening, full-text screening and grading with the mixed methods appraisal tool (MMAT). The Burchett framework for new vaccine introduction was used to identify indicators for vaccine-decision making and guided data extraction. Articles in our study represented a diverse range of perspectives and methodologies. Across articles, the importance of the disease, which included disease burden, costs of disease and political prioritization, coupled with economic factors related to vaccine price, affordability and financing were the most common criteria considered for new vaccine introduction. Our review identified two additional criteria in the decision-making process for vaccine introduction that were not included in the Burchett framework: communication and sociocultural considerations. Data from this review can support informed decision-making for vaccine introduction amongst policymakers and stakeholders in LMICs. |
Author | Chou, Victoria B Meyer, Diane Schlieff, Meike Limaye, Rupali Waheed, Dur-e-Nayab Muralidharan, Kirthini Guillaume, Dominique |
Author_xml | – sequence: 1 givenname: Dominique orcidid: 0000-0003-3963-4986 surname: Guillaume fullname: Guillaume, Dominique email: dguilla2@jhu.edu – sequence: 2 givenname: Diane surname: Meyer fullname: Meyer, Diane – sequence: 3 givenname: Dur-e-Nayab surname: Waheed fullname: Waheed, Dur-e-Nayab – sequence: 4 givenname: Meike surname: Schlieff fullname: Schlieff, Meike – sequence: 5 givenname: Kirthini surname: Muralidharan fullname: Muralidharan, Kirthini – sequence: 6 givenname: Victoria B surname: Chou fullname: Chou, Victoria B – sequence: 7 givenname: Rupali orcidid: 0000-0002-3883-9720 surname: Limaye fullname: Limaye, Rupali |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36315461$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkc1LHTEUxUOx1M9tlyXQTbsYzdfMvOlOpFZB6MZ9yNzc1NiZZJpktM-_vqPvCUUQV7mQ3zn3cs4-2QkxICEfOTvmrJMnN2imOJzAgwHWiXdkj6uGVULIdue_eZfs53zLGFdK1R_Irmwkr1XD98jfcwMlpkx9cMOMAXz4RcsN0in5mHzxD6b4GGh09M7A8ouZ9mu67PSwHs1vfJLSId5X1ARLR2_tgJUPEEekEOdQksf8jRqaIU6P7gnvPN4fkvfODBmPtu8BuT7_fn12UV39_HF5dnpVgZKsVL2wnatR9LZRCkWLnbO8da4RPVsph8bWTEiwzcqAYHXrpOwUAkrT9QI6eUC-bGynFP_MmIsefQYcBhMwzlmLVrJGyZo1C_r5BXob5xSW47RkNRf1qmVqoT5tqbkf0eolp9GktX6OdAHUBoAUc07oNPjyFGJJxg-aM_3YnN40p7fNLbLjF7Jn51cFXzeCOE9vsf8ASpSuZA |
CitedBy_id | crossref_primary_10_2147_AHMT_S394119 crossref_primary_10_1186_s41182_023_00564_2 crossref_primary_10_1093_heapol_czae059 crossref_primary_10_1080_21645515_2024_2411823 crossref_primary_10_7759_cureus_76223 crossref_primary_10_3390_vaccines12020201 crossref_primary_10_1093_infdis_jiaf038 crossref_primary_10_3390_vaccines12020184 crossref_primary_10_1002_jmv_29900 crossref_primary_10_3390_vaccines12030337 crossref_primary_10_1111_inr_13022 crossref_primary_10_3390_vaccines12070767 crossref_primary_10_1080_16549716_2023_2281065 crossref_primary_10_1371_journal_pone_0294480 crossref_primary_10_1016_S2214_109X_23_00457_6 |
Cites_doi | 10.3389/fpubh.2022.860809 10.1093/infdis/jiw601 10.1016/j.coi.2021.03.006 10.1371/journal.pntd.0002127 10.1200/GO.20.00504 10.1586/14760584.2016.1166961 10.1186/1471-2288-8-45 10.1098/rstb.2011.0046 10.15585/mmwr.mm6745a2 10.1097/XEB.0000000000000050 10.1016/j.vaccine.2018.07.063 10.1016/j.vaccine.2018.06.001 10.1093/heapol/czr049 10.1016/S0264-410X(03)00533-4 10.1093/heapol/czs039 10.1186/s12936-021-03966-x 10.1016/j.vaccine.2012.04.027 10.15171/ijhpm.2017.37 10.1093/heapol/czs040 10.1016/j.vaccine.2020.03.005 10.1016/j.vaccine.2021.06.074 10.1377/hlthaff.2015.1418 10.1016/j.vaccine.2021.02.055 10.1093/heapol/czs035 10.1093/infdis/jiab284 10.1186/s12874-018-0611-x 10.1186/s12992-021-00745-w 10.2174/1875035400902010113 10.1186/1475-2875-9-182 10.1093/heapol/czs036 10.1093/heapol/czs037 10.1056/NEJMp2029466 10.1186/s12936-016-1197-6 10.3329/jhpn.v31i2.16385 10.1016/j.vaccine.2004.11.044 10.1016/S0140-6736(20)30068-4 10.1016/S0140-6736(20)32657-X 10.3389/fpubh.2021.598625 10.1590/S0102-311X2010000500012 10.1080/14760584.2019.1574224 10.1177/1049732305276687 10.1186/s13012-021-01101-7 10.1093/heapol/czz027 10.1016/j.vaccine.2013.05.032 10.1177/2059799118789021 10.1080/21645515.2021.1893062 10.1186/s12889-021-12196-4 10.1016/j.socscimed.2007.05.054 10.1016/j.ypmed.2020.106335 10.1016/j.vaccine.2019.05.046 10.1093/heapol/czw038 10.1016/j.vaccine.2014.10.090 10.3389/fpubh.2022.799984 10.1016/j.vaccine.2018.11.062 10.1016/j.vaccine.2014.12.073 10.1186/s12889-015-1638-0 10.1590/S1020-49892009001100003 10.7326/M18-0850 10.1016/j.vaccine.2010.02.043 |
ContentType | Journal Article |
Copyright | Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine 2022. This work is written by (a) US Government employee(s) and is in the public domain in the US. 2022 Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine 2022. This work is written by (a) US Government employee(s) and is in the public domain in the US. |
Copyright_xml | – notice: Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine 2022. This work is written by (a) US Government employee(s) and is in the public domain in the US. 2022 – notice: Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine 2022. This work is written by (a) US Government employee(s) and is in the public domain in the US. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QJ 7T2 7TQ 8BJ C1K DHY DON FQK JBE K9. 7X8 |
DOI | 10.1093/heapol/czac092 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Applied Social Sciences Index & Abstracts (ASSIA) Health and Safety Science Abstracts (Full archive) PAIS Index International Bibliography of the Social Sciences (IBSS) Environmental Sciences and Pollution Management PAIS International PAIS International (Ovid) International Bibliography of the Social Sciences International Bibliography of the Social Sciences ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Health & Safety Science Abstracts International Bibliography of the Social Sciences (IBSS) Applied Social Sciences Index and Abstracts (ASSIA) PAIS International Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic MEDLINE ProQuest Health & Medical Complete (Alumni) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health |
EISSN | 1460-2237 |
EndPage | 376 |
ExternalDocumentID | 36315461 10_1093_heapol_czac092 10.1093/heapol/czac092 |
Genre | Journal Article Scoping Review |
GroupedDBID | --- -E4 .2P .I3 .ZR 0R~ 18M 1TH 29I 2WC 4.4 482 48X 53G 5GY 5VS 5WA 6.Y 70D A8Z AABZA AACZT AAJKP AAJQQ AAMVS AAOGV AAPGJ AAPNW AAPQZ AAPXW AARHZ AASNB AAUQX AAVAP AAWDT AAWTL ABBHK ABEUO ABIVO ABIXL ABJNI ABKDP ABLJU ABNKS ABPTD ABQLI ABQTQ ABSAR ABSMQ ABWST ABXSQ ABXVV ABYLZ ABZBJ ACFRR ACGFO ACGFS ACHQT ACMRT ACPQN ACPRK ACUFI ACUTJ ACUTO ACVHY ADACV ADBBV ADEYI ADEZT ADGZP ADHKW ADHZD ADJQC ADOCK ADPDF ADQBN ADRIX ADRTK ADULT ADVEK ADYVW ADZXQ AEAAH AEGPL AEJOX AEJYH AEKPW AEKSI AEMDU AENEX AENZO AEPUE AETBJ AEWNT AFFZL AFIYH AFOFC AFRAH AFSHK AFXEN AFYAG AGINJ AGKEF AGKRT AGQXC AGSYK AHMBA AHXPO AIAGR AIJHB AILCM AJEEA ALMA_UNASSIGNED_HOLDINGS ALUQC APIBT APJGH APWMN AQDSO AQKUS ASPBG ATTQO AVWKF AXUDD AZFZN BAWUL BAYMD BCRHZ BEYMZ BHONS BTRTY BVRKM BWUDY BZKNY C1A C45 CAG CDBKE CNZYI COF CS3 CZ4 DAKXR DIK DILTD DU5 D~K E3Z EBD EBS EE~ EGZRM EIHJH EJD EMOBN ESTFP F5P F9B FEDTE FLUFQ FOEOM FOTVD FQBLK FTKQU GAUVT GJXCC GX1 H13 H5~ HAR HVGLF HW0 HZ~ IOX J21 JENOY JKPJF JPL JPM JSODD JST JVCUD KAQDR KBUDW KC5 KOP KQ8 KSI KSN M-Z M49 MBLQV MS~ N9A NGC NOMLY NOYVH NPJNY NTWIH NU- NVLIB O0~ O9- OAWHX ODMLO OJQWA OK1 OPAEJ OVD O~Y P2P PAFKI PB- PEELM PQQKQ Q1. Q5Y QBD R44 RD5 RIG RNI ROL ROX ROZ RPM RUSNO RW1 RXO RZF RZO SA0 SV3 TJX TMA TOX TR2 W8F WH7 WOQ X7H YAYTL YHZ YKOAZ YXANX ZKX ~91 ~OX ~OY ~P0 AAYXX ABEJV ABGNP ABPQP ADMHG AGQZG AHGBF ALXQX AMHCJ AMNDL CITATION JXSIZ CGR CUY CVF ECM EIF NPM 7QJ 7T2 7TQ 8BJ C1K DHY DON FQK JBE K9. 7X8 |
ID | FETCH-LOGICAL-c430t-b2d9f5e2bd644e27e9fd17ff62b084fead5023cd68ac2057f3394ece3a9b2c93 |
IEDL.DBID | TOX |
ISSN | 1460-2237 0268-1080 |
IngestDate | Fri Jul 11 00:42:05 EDT 2025 Thu Jul 03 23:40:05 EDT 2025 Mon Jul 21 06:05:12 EDT 2025 Tue Jul 01 01:15:56 EDT 2025 Thu Apr 24 23:00:51 EDT 2025 Wed Aug 28 03:18:19 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Decision-making vaccine introduction low- and middle-income countries policy evaluation |
Language | English |
License | This work is written by (a) US Government employee(s) and is in the public domain in the US. Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine 2022. This work is written by (a) US Government employee(s) and is in the public domain in the US. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c430t-b2d9f5e2bd644e27e9fd17ff62b084fead5023cd68ac2057f3394ece3a9b2c93 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
ORCID | 0000-0003-3963-4986 0000-0002-3883-9720 |
OpenAccessLink | https://academic.oup.com/heapol/article-pdf/38/3/363/49543108/czac092.pdf |
PMID | 36315461 |
PQID | 3051258704 |
PQPubID | 34190 |
PageCount | 14 |
ParticipantIDs | proquest_miscellaneous_2730643506 proquest_journals_3051258704 pubmed_primary_36315461 crossref_citationtrail_10_1093_heapol_czac092 crossref_primary_10_1093_heapol_czac092 oup_primary_10_1093_heapol_czac092 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-03-16 |
PublicationDateYYYYMMDD | 2023-03-16 |
PublicationDate_xml | – month: 03 year: 2023 text: 2023-03-16 day: 16 |
PublicationDecade | 2020 |
PublicationPlace | UK |
PublicationPlace_xml | – name: UK – name: England – name: Oxford |
PublicationTitle | Health policy and planning |
PublicationTitleAlternate | Health Policy Plan |
PublicationYear | 2023 |
Publisher | Oxford University Press Oxford Publishing Limited (England) |
Publisher_xml | – name: Oxford University Press – name: Oxford Publishing Limited (England) |
References | Li (2023071115181474900_R35) 2021; 397 Brooks (2023071115181474900_R8) 2012; 27 Tricco (2023071115181474900_R57) 2018; 169 Guignard (2023071115181474900_R24) 2019; 18 Ngcobo (2023071115181474900_R45) 2021; 71 Blau (2023071115181474900_R6) 2015; 33 Brisson (2023071115181474900_R7) 2020; 395 DeRoeck (2023071115181474900_R19) 2003; 22 Milstien (2023071115181474900_R39) 2010; 9 Burchett (2023071115181474900_R9) 2012; 27 DeRoeck (2023071115181474900_R18) 2005; 23 Wallace (2023071115181474900_R64) 2017; 6 Gordon (2023071115181474900_R23) 2012; 27 Kollamparambil (2023071115181474900_R34) 2021; 21 Amponsah-Dacosta (2023071115181474900_R1) 2022; 10 Thomas (2023071115181474900_R56) 2008; 8 VanderEnde (2023071115181474900_R62) 2019; 67 Burns (2023071115181474900_R11) 2009; 26 NCI (2023071115181474900_R43) 2021 Ngcobo (2023071115181474900_R44) 2012; 30 Ikilezi (2023071115181474900_R30) 2020; 38 Shinkafi-Bagudu (2023071115181474900_R54) 2020; 6 Gerberding (2023071115181474900_R22) 2021; 384 Hasan (2023071115181474900_R27) 2018; 36 Shen (2023071115181474900_R53) 2016; 35 GAVI TVA (2023071115181474900_R21) 2020 Makinen (2023071115181474900_R37) 2012; 27 Steffen (2023071115181474900_R55) 2021; 39 Peters (2023071115181474900_R49) 2015; 13 Hajjeh (2023071115181474900_R26) 2011; 366 Khosa (2023071115181474900_R33) 2022; 10 Milondzo (2023071115181474900_R38) 2021; 9 Douglas (2023071115181474900_R20) 2013; 7 Bell (2023071115181474900_R5) 2019; 34 Howard (2023071115181474900_R28) 2018; 36 Tsui (2023071115181474900_R58) 2009; 2 Munira (2023071115181474900_R41) 2007; 65 Wiysonge (2023071115181474900_R68) 2021; 18 Otieno (2023071115181474900_R48) 2021; 16 WHO (2023071115181474900_R66) 2022 Lindstrand (2023071115181474900_R36) 2021; 224 Van Der Putten (2023071115181474900_R63) 2015; 15 Decouttere (2023071115181474900_R14) 2021; 17 Aromataris (2023071115181474900_R2) 2017 Hadisoemarto (2023071115181474900_R25) 2016; 31 Hsieh (2023071115181474900_R29) 2005; 15 Piñeros (2023071115181474900_R50) 2010; 26 Nha HONG (2023071115181474900_R46) 2018 Uddin (2023071115181474900_R60) 2013; 31 Wilson (2023071115181474900_R67) 2021; 39 Ba-Nguz (2023071115181474900_R3) 2017; 216 Unwin (2023071115181474900_R61) 2021; 20 Wonodi (2023071115181474900_R69) 2012; 27 Nzabonimpa (2023071115181474900_R47) 2018; 11 Tsu (2023071115181474900_R59) 2021; 144 DeRoeck (2023071115181474900_R17) 2004; 22 WHO (2023071115181474900_R65) 2021 Ba-Nguz (2023071115181474900_R4) 2019; 37 Munn (2023071115181474900_R42) 2018; 18 Rattanavipapong (2023071115181474900_R51) 2020; 9 de Oliveira (2023071115181474900_R16) 2016; 15 Romore (2023071115181474900_R52) 2016; 15 Clemens (2023071115181474900_R12) 2004; 22 Jauregui (2023071115181474900_R31) 2015; 33 de Oliveira (2023071115181474900_R15) 2013; 31 Muangchana (2023071115181474900_R40) 2010; 28 KFF (2023071115181474900_R32) 2022 Dawa (2023071115181474900_R13) 2019; 37 Burchett (2023071115181474900_R10) 2012; 27 |
References_xml | – volume: 10 start-page: 1 year: 2022 ident: 2023071115181474900_R33 article-title: Vaccine hesitancy drives low human papillomavirus vaccination coverage in girls attending public schools in South Africa publication-title: Frontiers in Public Health doi: 10.3389/fpubh.2022.860809 – volume: 216 start-page: S109 year: 2017 ident: 2023071115181474900_R3 article-title: The role of National Immunization Technical Advisory Groups (NITAGs) in the introduction of inactivated polio vaccine: experience of the Indonesia and Uganda NITAGs publication-title: The Journal of Infectious Diseases doi: 10.1093/infdis/jiw601 – volume: 71 start-page: 21 year: 2021 ident: 2023071115181474900_R45 article-title: Reflection: burden of cervical cancer in Sub-Saharan Africa and progress with HPV vaccination publication-title: Current Opinion in Immunology doi: 10.1016/j.coi.2021.03.006 – volume: 7 year: 2013 ident: 2023071115181474900_R20 article-title: Will dengue vaccines be used in the public sector and if so, how? Findings from an 8-country survey of policymakers and opinion leaders publication-title: PLoS Neglected Tropical Diseases doi: 10.1371/journal.pntd.0002127 – volume: 6 start-page: 1746 year: 2020 ident: 2023071115181474900_R54 article-title: Global partnerships for HPV vaccine must look beyond national income publication-title: JCO Global Oncology doi: 10.1200/GO.20.00504 – volume: 15 start-page: 1295 year: 2016 ident: 2023071115181474900_R16 article-title: Pneumococcal conjugate vaccine introduction in Latin America and the Caribbean: progress and lessons learned publication-title: Expert Review of Vaccines doi: 10.1586/14760584.2016.1166961 – year: 2017 ident: 2023071115181474900_R2 article-title: 8.2 Concepts and considerations for mixed methods systematic reviews – volume: 8 year: 2008 ident: 2023071115181474900_R56 article-title: Methods for the thematic synthesis of qualitative research in systematic reviews publication-title: BMC Medical Research Methodology doi: 10.1186/1471-2288-8-45 – volume: 366 start-page: 2827 year: 2011 ident: 2023071115181474900_R26 article-title: Accelerating introduction of new vaccines: barriers to introduction and lessons learned from the recent Haemophilus influenzae type b vaccine experience publication-title: Philosophical Transactions of the Royal Society B: Biological Sciences doi: 10.1098/rstb.2011.0046 – volume: 67 start-page: 1261 year: 2019 ident: 2023071115181474900_R62 article-title: Global routine vaccination coverage — 2017 publication-title: MMWR Morbidity and Mortality Weekly Report doi: 10.15585/mmwr.mm6745a2 – volume: 13 start-page: 141 year: 2015 ident: 2023071115181474900_R49 article-title: Guidance for conducting systematic scoping reviews publication-title: International Journal of Evidence Based Healthcare doi: 10.1097/XEB.0000000000000050 – volume: 36 start-page: 5536 year: 2018 ident: 2023071115181474900_R28 article-title: The role of National Immunisation Technical Advisory Groups (NITAGs) in strengthening national vaccine decision-making: a comparative case study of Armenia, Ghana, Indonesia, Nigeria, Senegal and Uganda publication-title: Vaccine doi: 10.1016/j.vaccine.2018.07.063 – volume: 36 start-page: 4939 year: 2018 ident: 2023071115181474900_R27 article-title: Using pneumococcal and rotavirus surveillance in vaccine decision-making: a series of case studies in Bangladesh, Armenia and the Gambia publication-title: Vaccine doi: 10.1016/j.vaccine.2018.06.001 – volume: 27 start-page: ii62 year: 2012 ident: 2023071115181474900_R10 article-title: National decision-making on adopting new vaccines: a systematic review publication-title: Health Policy and Planning doi: 10.1093/heapol/czr049 – volume: 22 start-page: 121 year: 2003 ident: 2023071115181474900_R19 article-title: Policymakers’ views on dengue fever/dengue haemorrhagic fever and the need for dengue vaccines in four southeast Asian countries publication-title: Vaccine doi: 10.1016/S0264-410X(03)00533-4 – volume: 27 start-page: 50 year: 2012 ident: 2023071115181474900_R8 article-title: Country planning for health interventions under development: lessons from the malaria vaccine decision-making framework and implications for other new interventions Downloaded from KEY MESSAGES publication-title: Health Policy and Planning doi: 10.1093/heapol/czs039 – volume: 20 start-page: 1 year: 2021 ident: 2023071115181474900_R61 article-title: Analysis of the potential for a malaria vaccine to reduce gaps in malaria intervention coverage publication-title: Malaria Journal doi: 10.1186/s12936-021-03966-x – volume: 30 start-page: C9 year: 2012 ident: 2023071115181474900_R44 article-title: The decision making process on new vaccines introduction in South Africa publication-title: Vaccine doi: 10.1016/j.vaccine.2012.04.027 – volume: 6 start-page: 707 year: 2017 ident: 2023071115181474900_R64 article-title: How are new vaccines prioritized in low-income countries? A case study of human papilloma virus vaccine and pneumococcal conjugate vaccine in Uganda publication-title: International Journal of Health Policy and Management doi: 10.15171/ijhpm.2017.37 – volume: 27 start-page: ii17 year: 2012 ident: 2023071115181474900_R23 article-title: Introducing multiple vaccines in low- and lower-middle-income countries: issues, opportunities and challenges publication-title: Health Policy and Planning doi: 10.1093/heapol/czs040 – volume: 38 start-page: 3447 year: 2020 ident: 2023071115181474900_R30 article-title: Determinants of geographical inequalities for DTP3 vaccine coverage in sub-Saharan Africa publication-title: Vaccine doi: 10.1016/j.vaccine.2020.03.005 – volume: 39 start-page: 5277 year: 2021 ident: 2023071115181474900_R67 article-title: HPV vaccine acceptance in West Africa: a systematic literature review publication-title: Vaccine doi: 10.1016/j.vaccine.2021.06.074 – volume: 35 start-page: 272 year: 2016 ident: 2023071115181474900_R53 article-title: Country ownership and gavi transition: comprehensive approaches to supporting new vaccine introduction publication-title: Health Affairs doi: 10.1377/hlthaff.2015.1418 – volume: 39 start-page: 2146 year: 2021 ident: 2023071115181474900_R55 article-title: Evidence-informed vaccination decision-making in countries: progress, challenges and opportunities publication-title: Vaccine doi: 10.1016/j.vaccine.2021.02.055 – year: 2022 ident: 2023071115181474900_R66 article-title: WHO Evidence Considerations for Vaccine Policy Development (ECVP) – volume: 22 start-page: 322 year: 2004 ident: 2023071115181474900_R17 article-title: The importance of engaging policy-makers at the outset to guide research on and introduction of vaccines: the use of policy-maker surveys publication-title: Journal of Health, Population, and Nutrition – volume: 27 start-page: ii5 year: 2012 ident: 2023071115181474900_R9 article-title: New vaccine adoption: qualitative study of national decision-making processes in seven low- and middle-income countries publication-title: Health Policy and Planning doi: 10.1093/heapol/czs035 – volume: 224 start-page: S452 year: 2021 ident: 2023071115181474900_R36 article-title: The world of immunization: achievements, challenges, and strategic vision for the next decade publication-title: The Journal of Infectious Diseases doi: 10.1093/infdis/jiab284 – volume: 18 year: 2018 ident: 2023071115181474900_R42 article-title: Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach publication-title: BMC Medical Research Methodology doi: 10.1186/s12874-018-0611-x – volume: 17 start-page: 1 year: 2021 ident: 2023071115181474900_R14 article-title: Advancing sustainable development goals through immunization: a literature review publication-title: Globalization and Health doi: 10.1186/s12992-021-00745-w – volume: 2 start-page: 113 year: 2009 ident: 2023071115181474900_R58 article-title: Policy development for human papillomavirus vaccine introduction in low-resource settings publication-title: The Open Vaccine Journal doi: 10.2174/1875035400902010113 – volume: 9 year: 2010 ident: 2023071115181474900_R39 article-title: WHO policy development processes for a new vaccine: case study of malaria vaccines publication-title: Malaria Journal doi: 10.1186/1475-2875-9-182 – volume: 27 start-page: ii39 year: 2012 ident: 2023071115181474900_R37 article-title: New vaccine adoption in lower-middle-income countries publication-title: Health Policy and Planning doi: 10.1093/heapol/czs036 – volume: 27 start-page: ii27 year: 2012 ident: 2023071115181474900_R69 article-title: Using social network analysis to examine the decision-making process on new vaccine introduction in Nigeria publication-title: Health Policy and Planning doi: 10.1093/heapol/czs037 – volume: 384 start-page: 393 year: 2021 ident: 2023071115181474900_R22 article-title: Vaccine innovations — past and future publication-title: New England Journal of Medicine doi: 10.1056/NEJMp2029466 – volume: 15 year: 2016 ident: 2023071115181474900_R52 article-title: Policy analysis for deciding on a malaria vaccine RTS,S in Tanzania publication-title: Malaria Journal doi: 10.1186/s12936-016-1197-6 – volume: 31 year: 2013 ident: 2023071115181474900_R60 article-title: Introduction of new vaccines: decision-making process in Bangladesh publication-title: Journal of Health, Population, and Nutrition doi: 10.3329/jhpn.v31i2.16385 – year: 2021 ident: 2023071115181474900_R43 article-title: Human Papillomavirus (HPV) Vaccines - National Cancer Institute – year: 2018 ident: 2023071115181474900_R46 article-title: MIXED METHODS APPRAISAL TOOL (MMAT) VERSION 2018 User guide – volume: 23 start-page: 2762 year: 2005 ident: 2023071115181474900_R18 article-title: Policymakers’ views regarding the introduction of new-generation vaccines against typhoid fever, shigellosis and cholera in Asia publication-title: Vaccine doi: 10.1016/j.vaccine.2004.11.044 – volume: 395 year: 2020 ident: 2023071115181474900_R7 article-title: Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries publication-title: The Lancet doi: 10.1016/S0140-6736(20)30068-4 – volume: 397 start-page: 398 year: 2021 ident: 2023071115181474900_R35 article-title: Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study publication-title: The Lancet doi: 10.1016/S0140-6736(20)32657-X – volume: 9 start-page: 1 year: 2021 ident: 2023071115181474900_R38 article-title: Misinformation drives low human papillomavirus vaccination coverage in South African Girls Attending Private Schools publication-title: Frontiers in Public Health doi: 10.3389/fpubh.2021.598625 – volume: 26 start-page: 900 year: 2010 ident: 2023071115181474900_R50 article-title: HPV vaccine introduction at the local level in a developing country: attitudes and criteria among key actors publication-title: Cadernos de Saúde Pública doi: 10.1590/S0102-311X2010000500012 – volume: 18 start-page: 119 year: 2019 ident: 2023071115181474900_R24 article-title: Introducing new vaccines in low- and middle-income countries: challenges and approaches publication-title: Expert Review of Vaccines doi: 10.1080/14760584.2019.1574224 – volume: 15 start-page: 1277 year: 2005 ident: 2023071115181474900_R29 article-title: Three approaches to qualitative content analysis publication-title: Qualitative Health Research doi: 10.1177/1049732305276687 – volume: 9 start-page: 439 year: 2020 ident: 2023071115181474900_R51 article-title: Comparing 3 approaches for making vaccine adoption decisions in Thailand publication-title: International Journal of Health Policy and Management – volume: 16 start-page: 1 year: 2021 ident: 2023071115181474900_R48 article-title: Decision-making process for introduction of maternal vaccines in Kenya, 2017–2018 publication-title: Implementation Science doi: 10.1186/s13012-021-01101-7 – volume: 34 start-page: 271 year: 2019 ident: 2023071115181474900_R5 article-title: Value and effectiveness of National Immunization Technical Advisory Groups in low- and middle-income countries: a qualitative study of global and national perspectives publication-title: Health Policy and Planning doi: 10.1093/heapol/czz027 – volume: 31 start-page: C114 year: 2013 ident: 2023071115181474900_R15 article-title: Systematic documentation of new vaccine introduction in selected countries of the Latin American Region publication-title: Vaccine doi: 10.1016/j.vaccine.2013.05.032 – volume: 11 start-page: 1 year: 2018 ident: 2023071115181474900_R47 article-title: Quantitizing and qualitizing (im-)possibilities in mixed methods research publication-title: Methodological Innovations doi: 10.1177/2059799118789021 – volume: 18 start-page: 1 year: 2021 ident: 2023071115181474900_R68 article-title: Vaccine hesitancy in the era of COVID-19: could lessons from the past help in divining the future? publication-title: Human Vaccines and Immunotherapeutics doi: 10.1080/21645515.2021.1893062 – year: 2020 ident: 2023071115181474900_R21 article-title: Annual progress report 2020 – volume: 21 start-page: 1 year: 2021 ident: 2023071115181474900_R34 article-title: COVID19 vaccine intentions in South Africa: health communication strategy to address vaccine hesitancy publication-title: BMC Public Health doi: 10.1186/s12889-021-12196-4 – volume: 65 start-page: 1751 year: 2007 ident: 2023071115181474900_R41 article-title: What influences government adoption of vaccines in developing countries? A policy process analysis publication-title: Social Science & Medicine doi: 10.1016/j.socscimed.2007.05.054 – volume: 144 year: 2021 ident: 2023071115181474900_R59 article-title: National implementation of HPV vaccination programs in low-resource countries: lessons, challenges, and future prospects publication-title: Preventive Medicine doi: 10.1016/j.ypmed.2020.106335 – year: 2021 ident: 2023071115181474900_R65 article-title: WHO recommends groundbreaking malaria vaccine for children at risk – volume: 37 start-page: 3646 year: 2019 ident: 2023071115181474900_R4 article-title: Supporting national immunization technical advisory groups (NITAGs) in resource-constrained settings. New strategies and lessons learned from the Task Force for Global Health’s Partnership for influenza vaccine introduction publication-title: Vaccine doi: 10.1016/j.vaccine.2019.05.046 – volume: 31 start-page: 1079 year: 2016 ident: 2023071115181474900_R25 article-title: Introduction of pentavalent vaccine in Indonesia: a policy analysis publication-title: Health Policy and Planning doi: 10.1093/heapol/czw038 – volume: 33 start-page: 28 year: 2015 ident: 2023071115181474900_R31 article-title: Evidence-based decision-making for vaccine introductions: overview of the ProVac International Working Group’s experience HHS public access publication-title: Vaccine doi: 10.1016/j.vaccine.2014.10.090 – volume: 10 start-page: 1 year: 2022 ident: 2023071115181474900_R1 article-title: Human papillomavirus vaccination in South Africa: programmatic challenges and opportunities for integration with other adolescent health services? publication-title: Frontiers in Public Health doi: 10.3389/fpubh.2022.799984 – volume: 37 start-page: 464 year: 2019 ident: 2023071115181474900_R13 article-title: Developing a seasonal influenza vaccine recommendation in Kenya: process and challenges faced by the National Immunization Technical Advisory Group (NITAG) publication-title: Vaccine doi: 10.1016/j.vaccine.2018.11.062 – volume: 22 start-page: 233 year: 2004 ident: 2023071115181474900_R12 article-title: Translational research to assist policy decisions about introducing new vaccines in developing countries publication-title: Journal of Health, Population, and Nutrition – volume: 33 start-page: A34 year: 2015 ident: 2023071115181474900_R6 article-title: Strengthening national decision-making on immunization by building capacity for economic evaluation: implementing ProVac in Europe publication-title: Vaccine doi: 10.1016/j.vaccine.2014.12.073 – year: 2022 ident: 2023071115181474900_R32 article-title: The U.S. Government & Gavi, the vaccine alliance | KFF – volume: 15 year: 2015 ident: 2023071115181474900_R63 article-title: Stakeholders’ perception on including broader economic impact of vaccines in economic evaluations in low and middle income countries: a mixed methods study publication-title: BMC Public Health doi: 10.1186/s12889-015-1638-0 – volume: 26 start-page: 398 year: 2009 ident: 2023071115181474900_R11 article-title: Descriptive analysis of immunization policy decision making in the Americas publication-title: Revista Panamericana de Salud Publica = Pan American Journal of Public Health doi: 10.1590/S1020-49892009001100003 – volume: 169 start-page: 467 year: 2018 ident: 2023071115181474900_R57 article-title: PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation publication-title: Annals of Internal Medicine doi: 10.7326/M18-0850 – volume: 28 start-page: A104 year: 2010 ident: 2023071115181474900_R40 article-title: Immunization policy development in Thailand: the role of the advisory committee on immunization practice publication-title: Vaccine doi: 10.1016/j.vaccine.2010.02.043 |
SSID | ssj0014445 |
Score | 2.4561777 |
SecondaryResourceType | review_article |
Snippet | Abstract
Vaccination decision making in low- and middle-income countries (LMICs) has become increasingly complex, particularly in the context of numerous... Vaccination decision making in low- and middle-income countries (LMICs) has become increasingly complex, particularly in the context of numerous competing... |
SourceID | proquest pubmed crossref oup |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 363 |
SubjectTerms | Affordability Clinical decision making Criteria Data Data points Decision making Delivery of Health Care Developing Countries Disease Economic factors Extraction Financing Health care Health initiatives Humans Immunization Low income groups Medical screening Policy making Search methods Search strategies Sociocultural factors Subject headings Systematic review Vaccination Vaccines |
Title | Factors influencing the prioritization of vaccines by policymakers in low- and middle-income countries: a scoping review |
URI | https://www.ncbi.nlm.nih.gov/pubmed/36315461 https://www.proquest.com/docview/3051258704 https://www.proquest.com/docview/2730643506 |
Volume | 38 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1ZS8QwEA6yT4KIt-tFFMGnYNscu_VNxMUD9GWFfStpmsDibrvs4fXrnWm6hfVAn5ukpZOZ-ZKZ-YaQU8CoXFoXMhOnLQbnL9S5TDINQC6yIThwnyD7oG6exF1P9iqy6MkPIfyYn4NRGhWDc_OhTRCjtQUPjCz53cdeHS8QQsiakvHrlAWXs1DG9g1Nll6ls0ZWKzhIL7381smSzTfIir9Lo75EaJO8dXxTHNqvOoqAu6EA3Oho3C-QlMiXUtLC0RdtMFI-oek7HZWUv0P9bMupdFC8MqrzjA7LSwmGvAxDS8tuEXhgvqCaYpEKru4rWrZIt3PdvbphVccEZgQPpiyNsthJG6UZwBwbtWzssrDlnIrSoC0c7BoJPtpkqo3MjLLlOI-FNZbrOI1MzLdJIy9yu0uoDLULVWAUV0ZYzdsmyySCA0xH5aluEjb_p4mp2MSxqcUg8VFtnngZJJUMmuSsHj_yPBq_jjwBEf056GAuwaRSukkCpgvgGhgg0STH9WNQF4yB6NwWs0kCaA1BmAxUk-x4ydev4ooDoFTh3n--YJ8sY-d5TEcL1QFpTMczewj4ZJoeATK_vT8qN-gnAtfpUA |
linkProvider | Oxford University Press |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Factors+influencing+the+prioritization+of+vaccines+by+policymakers+in+low-+and+middle-income+countries%3A+a+scoping+review&rft.jtitle=Health+policy+and+planning&rft.au=Guillaume%2C+Dominique&rft.au=Meyer%2C+Diane&rft.au=Dur-e-Nayab+Waheed&rft.au=Schlieff%2C+Meike&rft.date=2023-03-16&rft.pub=Oxford+Publishing+Limited+%28England%29&rft.issn=0268-1080&rft.eissn=1460-2237&rft.volume=38&rft.issue=3&rft.spage=363&rft.epage=376&rft_id=info:doi/10.1093%2Fheapol%2Fczac092&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1460-2237&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1460-2237&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1460-2237&client=summon |